BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Duan T, Xu Z, Sun F, Wang Y, Zhang J, Luo C, Wang M. HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation. Biomed Pharmacother 2019;117:109121. [PMID: 31252265 DOI: 10.1016/j.biopha.2019.109121] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Ravichandran G, Rengan AK. Aptamer-Mediated Nanotheranostics for Cancer Treatment: A Review. ACS Appl Nano Mater 2020;3:9542-59. [DOI: 10.1021/acsanm.0c01785] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 5.5] [Reference Citation Analysis]
2 Li Y, Zheng X, Chu Q. Bio-based nanomaterials for cancer therapy. Nano Today 2021;38:101134. [DOI: 10.1016/j.nantod.2021.101134] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
3 Abu Samaan TM, Samec M, Liskova A, Kubatka P, Büsselberg D. Paclitaxel's Mechanistic and Clinical Effects on Breast Cancer. Biomolecules 2019;9:E789. [PMID: 31783552 DOI: 10.3390/biom9120789] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 15.3] [Reference Citation Analysis]
4 Chen TT, Peng S, Wang Y, Hu Y, Shen Y, Xu Y, Yin J, Liu C, Cao J. Improvement of Mitochondrial Activity and Fibrosis by Resveratrol Treatment in Mice with Schistosoma japonicum Infection. Biomolecules 2019;9:E658. [PMID: 31717714 DOI: 10.3390/biom9110658] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
5 Kargozar S, Baino F, Hamzehlou S, Hamblin MR, Mozafari M. Nanotechnology for angiogenesis: opportunities and challenges. Chem Soc Rev 2020;49:5008-57. [PMID: 32538379 DOI: 10.1039/c8cs01021h] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
6 Xue H, Qin L, Zhang L, Li X, Wu F, Wang W, Wang C, Diao W, Jiang B, Lian B, Wu J, Bai J, Sun T, Zhao C, Qu M, Yu W, Wang Y, Gao Z. Preparation of docetaxel-loaded, glycyrrhetinic acid-modified nanoparticles and their liver-targeting and antitumor activity. Exp Ther Med 2021;22:1144. [PMID: 34471430 DOI: 10.3892/etm.2021.10578] [Reference Citation Analysis]
7 Ali MY, Tariq I, Farhan Sohail M, Amin MU, Ali S, Pinnapireddy SR, Ali A, Schäfer J, Bakowsky U. Selective anti-ErbB3 aptamer modified sorafenib microparticles: In vitro and in vivo toxicity assessment. European Journal of Pharmaceutics and Biopharmaceutics 2019;145:42-53. [DOI: 10.1016/j.ejpb.2019.10.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
8 Fu Z, Xiang J. Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy. Int J Mol Sci 2020;21:E2793. [PMID: 32316469 DOI: 10.3390/ijms21082793] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
9 Li B, Zhao X, Zhang L, Cheng W. Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin. Front Oncol 2020;10:588533. [PMID: 33634018 DOI: 10.3389/fonc.2020.588533] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wu R, Zhang Z, Wang B, Chen G, Zhang Y, Deng H, Tang Z, Mao J, Wang L. Combination Chemotherapy of Lung Cancer - Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid-Polymer Hybrid Nanoparticles. Drug Des Devel Ther 2020;14:2249-61. [PMID: 32606595 DOI: 10.2147/DDDT.S246574] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 El-hammadi MM, Arias JL. Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines. Nanomaterials 2022;12:354. [DOI: 10.3390/nano12030354] [Reference Citation Analysis]
12 Yang C, Jiang Y, Hao SH, Yan XY, Hong F, Naranmandura H. Aptamers: an emerging navigation tool of therapeutic agents for targeted cancer therapy. J Mater Chem B 2021;10:20-33. [PMID: 34881767 DOI: 10.1039/d1tb02098f] [Reference Citation Analysis]
13 Škubník J, Pavlíčková V, Ruml T, Rimpelová S. Current Perspectives on Taxanes: Focus on Their Bioactivity, Delivery and Combination Therapy. Plants (Basel) 2021;10:569. [PMID: 33802861 DOI: 10.3390/plants10030569] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Jia W, Xie D, Li F, Wu X, Wang R, Yang L, Liu L, Yin W, Chang S. Evaluation the effect of nanoparticles on the structure of aptamers by analyzing the recognition dynamics of aptamer functionalized nanoparticles. Anal Chim Acta 2021;1183:338976. [PMID: 34627520 DOI: 10.1016/j.aca.2021.338976] [Reference Citation Analysis]
15 Hashemi M, Shamshiri A, Saeedi M, Tayebi L, Yazdian-Robati R. Aptamer-conjugated PLGA nanoparticles for delivery and imaging of cancer therapeutic drugs. Arch Biochem Biophys 2020;691:108485. [PMID: 32712288 DOI: 10.1016/j.abb.2020.108485] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Zhang L, Xu H, Wu X, Huang W, Zhang T, Hao P, Peng B, Zan X. A Strategy to Fight against Triple-Negative Breast Cancer: pH-Responsive Hexahistidine-Metal Assemblies with High-Payload Drugs. ACS Appl Bio Mater 2020;3:5331-41. [DOI: 10.1021/acsabm.0c00653] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
17 Chen Y, Deng Y, Zhu C, Xiang C. Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles. Biomed Pharmacother 2020;127:110181. [PMID: 32416561 DOI: 10.1016/j.biopha.2020.110181] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
18 Fu Z, Xiang J. Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy. Int J Mol Sci 2020;21:E9123. [PMID: 33266216 DOI: 10.3390/ijms21239123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
19 Ma Y, Yu S, Ni S, Zhang B, Kung ACF, Gao J, Lu A, Zhang G. Targeting Strategies for Enhancing Paclitaxel Specificity in Chemotherapy. Front Cell Dev Biol 2021;9:626910. [PMID: 33855017 DOI: 10.3389/fcell.2021.626910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Gadag S, Sinha S, Nayak Y, Garg S, Nayak UY. Combination Therapy and Nanoparticulate Systems: Smart Approaches for the Effective Treatment of Breast Cancer. Pharmaceutics 2020;12:E524. [PMID: 32521684 DOI: 10.3390/pharmaceutics12060524] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
21 Neerooa BNHM, Ooi LT, Shameli K, Dahlan NA, Islam JMM, Pushpamalar J, Teow SY. Development of Polymer-Assisted Nanoparticles and Nanogels for Cancer Therapy: An Update. Gels 2021;7:60. [PMID: 34067587 DOI: 10.3390/gels7020060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chen S, Song Z, Feng R. Recent Development of Copolymeric Nano-Drug Delivery System for Paclitaxel. ACAMC 2020;20:2169-89. [DOI: 10.2174/1871520620666200719001038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Zhang M, Du Y, Wang S, Chen B. A Review of Biomimetic Nanoparticle Drug Delivery Systems Based on Cell Membranes. Drug Des Devel Ther 2020;14:5495-503. [PMID: 33363358 DOI: 10.2147/DDDT.S282368] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
24 Zhu L, Zhao J, Guo Z, Liu Y, Chen H, Chen Z, He N. Applications of Aptamer-Bound Nanomaterials in Cancer Therapy. Biosensors (Basel) 2021;11:344. [PMID: 34562934 DOI: 10.3390/bios11090344] [Reference Citation Analysis]